Search results
Showing 2601 to 2650 of 3761 results for treatment
Molecular testing strategies for Lynch syndrome in people with colorectal cancer (HTG430)
Evidence-based recommendations on using immunohistochemistry or microsatellite instability testing to guide further testing for Lynch syndrome in people with colorectal cancer.
NICE has developed a medtech innovation briefing (MIB) on Thora 3Di for assessing asthma in children .
NICE has developed a medtech innovation briefing (MIB) on PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection .
Late stage assessment (LSA) guidance on transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis.
View recommendations for HTG757Show all sections
Resources, case studies and patient decision aids to show how you can use evidence to improve care and services
Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique) (HTG29)
Evidence-based recommendations on complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique). This involves complete surgical tumour removal with intraoperative heated chemotherapy, and is followed by postoperative intraperitoneal chemotherapy.
View recommendations for HTG29Show all sections
Sections for HTG29
Intramural urethral bulking procedures for stress urinary incontinence in women (HTG86)
Evidence-based recommendations on intramural urethral bulking procedures for stress urinary incontinence in women. Intramural urethral bulking aims to augment the urethral wall and increase the urethral closure force.
View recommendations for HTG86Show all sections
Sections for HTG86
These are the main stages in the multiple technology appraisal process used before April 2018.
exercise or when you cough, laugh or sneeze. The diagram below shows what treatments NICE recommends as options for managing stress...
NICE has developed a medtech innovation briefing (MIB) on PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes .
Trabecular stent bypass microsurgery for open-angle glaucoma (HTG432)
Evidence-based recommendations on trabecular stent bypass microsurgery for open-angle glaucoma. This involves inserting a hollow metal tube (stent) into the eye, to improve drainage of fluid from the eye.
This guidance has been replaced by NICE guideline CG43.
This guidance has been replaced by NICE technology appraisal guidance 58 [Replaced by NICE technology appraisal guidance 168].
Tegaderm CHG securement dressing for vascular access sites (MIB231)
NICE has developed a medtech innovation briefing (MIB) on Tegaderm CHG securement dressing for vascular access sites .
NICE has developed a medtech innovation briefing (MIB) on Optowire for measuring fractional flow reserve .
are no randomised studies on the use of radiotherapy/radiosurgery in the treatment of grade I meningioma. Though case series have shown...
alcohol-related problems. However, even with the most effective current treatment (for example, cognitive behavioural therapies and...
This can cause discomfort and problems with urination. There are some treatment options that don't involve surgery that NICE says you...
Balloon valvuloplasty for aortic valve stenosis in adults and children (HTG49)
Evidence-based recommendations on balloon valvuloplasty for aortic valve stenosis in adults and children. This involves inflating a balloon inserted into the narrow valve to widen it so that blood can flow out more easily.
View recommendations for HTG49Show all sections
Sections for HTG49
Pembrolizumab for adjuvant treatment of hepatocellular carcinoma [ID3994]
In development Reference number: GID-TA10895 Expected publication date: 29 October 2026
Flexible endoscopic treatment of a pharyngeal pouch (IPG513)
We have moved interventional procedures guidance 513 to become HealthTech guidance 367. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
NICE has developed a medtech innovation briefing (MIB) on VIDAvision for lung volume analysis in emphysema .
key outcomes should include symptoms, relapse rates, quality of life, treatment acceptability, experience of care, level of psychosocial...
For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?
applicable) Why this is important There is little evidence for the treatment of isoniazid resistant TB. This is the most common form of...
recommendationsThe only cannabis-based medicinal product available for the treatment of epilepsy is epidyolex, which is licensed...
recommendationsThe only cannabis-based medicinal product available for the treatment of epilepsy is epidyolex, which is licensed...
Membership details, terms of reference, future meeting dates and past meeting minutes for our interventional procedures advisory committee.
Membership details, terms of reference, future meeting dates and past meeting minutes for our interventional procedures advisory committee.
NICE has developed a medtech innovation briefing (MIB) on Acumen IQ sensor for predicting hypotension risk .
Cardiovascular disease. Patient decision aid on should I take a statin?
things or when you are stressed). Heart attacks and strokes need urgent treatment and can be life threatening. People who survive them...
committees and why she'd encourage you to get involved. Following my treatment for colorectal cancer, I wanted to contribute and improve...
Transilluminated powered phlebectomy for varicose veins (HTG16)
Evidence-based recommendations on transilluminated powered phlebectomy for varicose veins. This involves using a special light passed underneath the skin to see the veins and removing them by suction.
View recommendations for HTG16Show all sections
Sections for HTG16
Endovascular stent–graft placement in thoracic aortic aneurysms and dissections (HTG76)
Evidence-based recommendations on endovascular stent–graft placement in thoracic aortic aneurysms and dissections. This involves placing a stent covered in graft material inside the aorta under X-ray guidance.
View recommendations for HTG76Show all sections
Sections for HTG76
committees and why she'd encourage you to get involved. Following my treatment for colorectal cancer, I wanted to contribute and improve...
Single-incision short sling mesh insertion for stress urinary incontinence in women (HTG419)
Evidence-based recommendations on single-incision short sling mesh insertion for stress urinary incontinence in women. This involves putting 2 short slings around the tube that carries urine from the bladder to support it.
include local control, progression-free survival, overall survival, and treatment-related morbidity and mortality. In a very small...
health technologies in the NHS, clinical guidelines on the management and treatment of particular conditions and its ongoing development...
Awaiting development Reference number: GID-TA11826 Expected publication date: TBC
NICE has developed a medtech innovation briefing (MIB) on Smart One for measuring lung function .
the comparative efficacy and safety of different surgical and ablative treatments would be useful. Any explanatory notes(if applicable)...
Microwave ablation for the treatment of liver metastases (IPG406)
Interventional procedures, IPG406 - Issued: August 2011 --> This guidance has been updated and replaced by NICE interventional procedure guidance 553.
Cryotherapy as a primary treatment for prostate cancer (IPG145)
We have moved interventional procedures guidance 145 to become HealthTech guidance 91. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Ranibizumab for the treatment of diabetic macular oedema (TA237)
This guidance has been updated and replaced by NICE technology appraisal guidance 274.
Sorafenib for the treatment of advanced hepatocellular carcinoma (TA189)
This guidance has been replaced by NICE technology appraisal guidance 474.
Certolizumab pegol for the treatment of rheumatoid arthritis (TA186)
This guidance has been updated and replaced by NICE technology appraisal guidance 375.
Trabectedin for the treatment of relapsed ovarian cancer (TA222)
This guidance has been updated and replaced by NICE technology appraisal guidance 389.
Alteplase for the treatment of acute ischaemic stroke (TA122)
This guidance has been updated and replaced by NICE technology appraisal guidance 264 issued in September 2012.
This guidance has been updated and replaced by NICE guideline CG66 [partially updated by NICE guideline CG87]).
Leukomed Sorbact for preventing surgical site infection (HTG567)
Evidence-based recommendations on Leukomed Sorbact for preventing surgical site infection after caesarean section or vascular surgery.
Evidence-based recommendations on radiofrequency-assisted liver resection. This involves using high-frequency radio waves to remove the cancerous part of the liver with minimal blood loss.
View recommendations for HTG136Show all sections
Sections for HTG136